Retour

Validation of the Spasticity Related Quality of Life Questionnaire

- 29 janvier 2025 - 1  mn de lecture

The purpose of the study is to describe the psychometric properties (validity, reliability and responsiveness) of the SQOL-6D instrument in the context of routine clinical treatment of upper limb spasticity.

En rapport Clinical Trials

Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.
29 janvier 2025 1  mn de lecture

Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot...
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
29 janvier 2025 1  mn de lecture

Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
29 janvier 2025 1  mn de lecture

Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
29 janvier 2025 1  mn de lecture

Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
29 janvier 2025 1  mn de lecture

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
29 janvier 2025 1  mn de lecture

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
29 janvier 2025 1  mn de lecture

Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
29 janvier 2025 1  mn de lecture

Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
29 janvier 2025 1  mn de lecture

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
29 janvier 2025 1  mn de lecture

Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment